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Blimp-1 is considered an essential regulator of
the terminal differentiation of B cells into anti-
body-secreting plasma cells. We show here
that Rag1/ mice reconstituted with fetal liver
cells homozygous for a DNA-binding-deficient
mutant of Prdm1 (the gene encoding Blimp-1)
lack a defined plasma-cell compartment, yet
show detectable amounts of all immunoglobu-
lin isotypes. In vitro analysis revealed that
Blimp-1 is not required for the initiation of anti-
body secretion but is essential for subsequent
high immunoglobulin production. Blimp-1-in-
dependent differentiation was blocked at a pre-
plasmablast stage characterized by decreased
Pax5 expression and the activation of plasma-
cell genes. Analysis of Blimp-1-sufficient dif-
ferentiation revealed a phase prior to Blimp-1
expression in which several genes normally re-
pressed by Pax5 are re-expressed, suggesting
that plasma-cell differentiation is initiated by
the inhibition of Pax5 function. Our results indi-
cate that full plasma-cell differentiation but not
commitment to the plasma-cell fate requires
the expression of functional Blimp-1.
INTRODUCTION
The differentiation of B cells into antibody-secreting cells
(ASC) is a crucial component of the immune response. Af-
ter encountering antigen, B cells undergo multiple rounds
of division and have the ability to differentiate into plasma-
blasts, plasma cells, or memory B cells (Manz et al., 2005).
Plasmablasts are short-lived cycling ASC that are found
in extrafollicular foci in peripheral lymphoid organs and
resemble ASC generated after in vitro stimulation. In con-
trast, long-lived plasma cells are noncycling, found prefer-
entially in the bone marrow, and derive predominantly
from germinal centers (GC) (Manz et al., 2005). The GC
reaction also produces memory B cells that can rapidly
differentiate into ASC after re-exposure to antigen.A small number of transcription factors have been iden-
tified that guide the developmental program leading to
ASC differentiation (Kallies and Nutt, 2007; Shapiro-Shelef
andCalame, 2005). Interestingly, theevidence todate sug-
gests that this gene-regulatory network is dominated by
transcriptional repression. One group of factors, including
Pax5,Mitf, Bach2, andBCL6, are expressed in activated B
cells and act predominantly by repressing differentiation
(reviewed in Shapiro-Shelef and Calame, 2005). Pax5 re-
presses genes associated with the stem cell and non-B
lineage programs as well as a number of genes involved
in ASCdifferentiation, includingPrdm1 (the gene encoding
B lymphocyte-induced maturation protein-1 [Blimp-1]),
Xbp1, and Igj (J chain) (Delogu et al., 2006; Nera et al.,
2006; Reimold et al., 1996; Rinkenberger et al., 1996).
BCL6andBach2 suppressASCdevelopment in part by re-
pressingPrdm1 (Ochiai et al., 2006; Tunyaplin et al., 2004),
whereas Mitf represses another key regulator of the ASC
lineage, Irf4 (Lin et al., 2004).
Themolecularmechanismbywhich this repression cas-
cade is overcome to allow ASC formation remains unclear,
but it is known that differentiation andhigh immunoglobulin
(Ig) secretion require IRF-4, XBP-1, and Blimp-1 (Shapiro-
Shelef andCalame, 2005). IRF-4 is present at low amounts
throughout the B cell lineage, where it regulates isotype
switching. Upon differentiation, IRF-4 expression mark-
edly increases, which is essential for ASC formation and
Ig secretion (Klein et al., 2006; Sciammas et al., 2006).
XBP-1 is an ubiquitously expressed transcription factor
that directly controls aspects of the secretory pathway
and is strongly induced in ASC by a combination of loss
of Pax5-mediated gene repression andposttranscriptional
control by the unfolded protein response (UPR) in the en-
doplasmic reticulum (Iwakoshi et al., 2003; Reimold
et al., 1996). Finally, ASC development is also critically de-
pendent on Blimp-1, which has been termed the ‘‘master
regulator’’ of plasma-cell differentiation.
Blimp-1 is expressed in ASC from human and mouse
but is absent from earlier stages of B cell ontogeny (An-
gelin-Duclos et al., 2000; Kallies et al., 2004).Many studies
have contributed to the view that Blimp-1 is essential for Ig
secretionandASCdevelopment.Notably, ectopicBlimp-1
is sufficient to induce differentiation (Turner et al., 1994),
whereas the B cell-specific deletion of Prdm1 in mice
demonstrates a requirement for Blimp-1 in the generationImmunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 555
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2006; Shapiro-Shelef et al., 2003). Blimp-1-deficient mice
show reduced, but not absent, serum Ig and display se-
verely diminished antibody responses after immunization,
whereas inactivation of Prdm1 in preformed plasma cells
leads to the loss of this lineage (Shapiro-Shelef et al.,
2003, 2005). Gene-expression studies have shown that
Blimp-1 is essential to extinguish many aspects of the
mature B cell gene-expression program, including silenc-
ing of Myc (the gene encoding c-myc) and for the exit
from the cell cycle characteristic of terminal differentiation
(Shaffer et al., 2002). Blimp-1 also directly binds and re-
presses the promoters of Pax5, and potentially of Bcl6,
thereby providing a mechanism by which its induction
leads to ASC differentiation and loss of the B cell pheno-
type (Lin et al., 2002; Vasanwala et al., 2002).
To investigate the function of Blimp-1 in ASC, we intro-
duced gfp into thePrdm1 locus (Kallies et al., 2004). In het-
erozygous mice, quantitative changes of Blimp-1 expres-
sion, revealed by GFP, can be used to define distinct
stages in ASC ontogeny, with intermediate expression
associated with short-lived plasmablasts and high ex-
pression with long-lived plasma cells (Blink et al., 2005;
Kallies et al., 2004). We have now used this mouse strain
to investigate the earliest stages of ASC formation and
show here that Blimp-1 is dispensable for the initiation of
the ASC differentiation program. We propose that down-
modulation of Pax5 activity is the critical step that leads
to the formation of a preplasmablast that is capable of
secreting low amounts of Ig independent of Blimp-1 func-
tion. Blimp-1 is, however, essential for the progression
from this earliest stage in ASC formation leading to the full
manifestation of the transcriptional program and high-titer
antibody production.
RESULTS
Low Ig Secretion Occurs In Vivo
in the Absence of Blimp-1
By using Prdm1+/gfp mice, we have shown that Blimp-1 is
expressed in all ASC (Kallies et al., 2004) and, at a lower
level, in antigen-experienced T cells (Kallies et al., 2006).
Mice homozygous for the mutant allele die in utero, so
we generated chimeric mice by reconstituting irradiated
Rag1/ mice with Prdm1gfp/gfp fetal liver cells as de-
scribed (Kallies et al., 2004), calledPrdm1gfp/gfpmice here-
after. The Prdm1gfp allele expresses GFP and a truncated
Blimp-1 protein that is deficient in DNA binding and non-
functional, and therefore, this strategy enabled us to follow
B lymphopoiesis in the absence of wild-type Blimp-1.
ASC could be detected readily in the spleen of
Prdm1+/gfpmice by their intermediate to high GFP expres-
sion (Kallies et al., 2004). The majority of these cells ex-
pressed the ASC marker Syndecan-1 (Synd-1 or CD138)
and were low for CD19 (Figure 1A). In contrast,
Prdm1gfp/gfp mice lacked Synd-1 expression on GFP+
cells suggesting an absence of ASC (Figure 1A). In these
mice, however, we detected an increased population of
GFP+Synd-1 cells. Although a large fraction of these556 Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc.cells were T cells (Kallies et al., 2006), up to 50% were
CD19+ and belonged to the B cell lineage (Figure 1A).
ELISA analysis of serum showed that all Ig classes were
detectable in Prdm1gfp/gfp mice but were reduced to be-
tween 0.1%–10% of controls (Figure 1B). Immunoprecip-
itation of IgG from serum of these mice confirmed the low
amounts of Ig determined by ELISA (Figure 1C). This Ig
arose in Rag1/ mice reconstituted with hematopoietic
cells that were uniformly deficient for the Blimp-1 DNA-
binding domain, so these data demonstrated that some
Ig secretion occurred in the absence of wild-type Blimp-1.
The presence of Ig in the serum of Prdm1gfp/gfp mice
raised the question of whether this Ig derived from a dis-
tinct ASC population that was less dependent on Blimp-1
for its function. One isotype that appeared less affected
by the loss of Blimp-1 was IgA (Figure 1B). IgA is produced
mainly by specializedmucosal ASCof the gastro-intestinal
tract, so we tested whether these cells were functional in
the absence of Blimp-1 by assaying fecal IgA by ELISA
and mucosal IgA by immunohistochemistry. Fecal IgA
amounts in Prdm1gfp/gfp mice were reduced to 1% of
Prdm1+/gfp controls, but well above amounts found in
Rag1/ mice (Figure 1D). We were, however, unable to
locate any IgA-secreting cells in the lamina propria despite
the presence of IgA-switched B cells in intestinal follicles
(Figure 1E). These experiments demonstrated through
a number of approaches that Prdm1gfp/gfp mice lacked
bona fide ASC but contain cells that were capable of
low-titer Ig secretion.
Severely Impaired ASC Differentiation in Immunized
Blimp-1 Mutant Mice
We have shown previously that T cell-dependent (NP-
KLH) and -independent (LPS) antigens induce a transient
plasmablast population with lower Blimp-1 expression
than that of mature plasma cells (Kallies et al., 2004). In
order to examine whether this state could be induced in
the absence of Blimp-1, we injected Prdm1gfp/gfp or con-
trol Prdm1+/gfp mice with LPS and analyzed the spleens
at days 3 and 7. As expected, in Prdm1+/gfp mice, a sub-
stantial population of GFPintSynd-1+ plasmablasts was in-
duced by day 3. This population had resolved almost
completely by day 7, but substantially increased serum
IgM amounts were detectable by ELISA at this time point.
In contrast, no GFP+ plasmablasts or increased serum
IgM titers were detected in Prdm1gfp/gfp mice, suggesting
that the Prdm1gfp/gfp B cells failed to differentiate in re-
sponse to T-independent stimuli (Figure S1A in the Sup-
plemental Data available online).
In a second approach, we examined the development
of ASC in response to immunization with the T-dependent
antigen NP-KLH. In this model, NP-specific ASC can be
found initially in the spleen and appear at later time points
in the GFPhigh plasma-cell population in the spleen and
bonemarrow (Blink et al., 2005; Kallies et al., 2004). Immu-
nization of Prdm1gfp/gfpmice led to the formation of GCs in
spleen and the generation of antigen-specific memory B
cells (defined as NP binding, IgG1+B220+CD38highSynd-
1), which were comparable in numbers and frequency
Immunity
Antibody Secretion in the Absence of Blimp-1Figure 1. Blimp-1 Is Required for Most
but Not All Antibody Secretion In Vivo
(A) Flow cytometric analysis of spleens from
Rag1/ mice reconstituted with E14.5 fetal
liver cells of the indicated genotypes. Numbers
indicate the percentage of cells in each quad-
rant. Data are representative of at least three
experiments.
(B) Serum Ig titers of individual mice as in (A)
were determined by ELISA. Bar graphs repre-
sent the means.
(C) Immunoprecipitation and immunoblotting
of serum IgG and Igk from Prdm1+/gfp and
Prdm1gfp/gfpmice in serial dilution as indicated.
A representative of two experiments is shown.
(D) Fecal IgA amounts of mice as in (A) were
assayed by ELISA. Data are mean derived
from five mice of each genotype ± SD.
(E) Immunohistochemical staining for mucosal
IgA. Although both genotypes showed normal
switching to IgA, staining brown, within the iso-
lated lymphoid follicles (ILF), Prdm1gfp/gfp mice
lacked IgA+ ASC in the lamina propria (LP) and
IgA staining in the epithelial cells (E) responsi-
ble for the transport of IgA to the gut lumen.
Scale bars represent 50 mM. Data are repre-
sentative of four mice of each genotype.of somatic hypermutations between Prdm1gfp/gfp and
wild-type mice (data not shown). In keeping with pub-
lished data (Shapiro-Shelef et al., 2003), no isotype-
switched, NP-specific ASC were found in the bone
marrow of immunized Prdm1gfp/gfp mice, although small
ELIspots were detected in the spleen at each time point
(Figure S1B). These data again provide evidence for the
induction of low specific Ig secretion in the absence of
Blimp-1.ASC Differentiation Is Induced but Abortive
in the Absence of Blimp-1 In Vitro
To further investigate the dependence of Ig production on
Blimp-1, purified resting splenic B cells were cultured in
conditions that mimic T cell help (anti-CD40+IL4+IL5) or
microbial stimuli (LPS) for 4 days and then analyzed for
ASC phenotype and Ig production (Hasbold et al., 2004;
Kallies et al., 2004). As expected, the Prdm1+/gfp cultures
contained GFP+ cells (Figure 2A), which we have shown toImmunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 557
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the Absence of Functional Blimp-1
(A) Resting splenic B cells of the indicated ge-
notypes were cultured in the presence of LPS
or a combination of anti-CD40+IL4+IL5 for
4 days and examined for GFP and Synd-1
expression.
(B) Cultured B cells as in (A) were assayed for
Igk secretion by ELISpot. Data represent the
mean numbers of ELISpots per 200 cells from
triplicate wells ± SEM.
(C) Representative ELISpot wells showing
predominantly small spots in Prdm1gfp/gfp cul-
tures.
(D) Total Igk production from cultures as in (A).
Data are presented as the mean of samples
assayed in triplicate ± SD. Data in (A)–(D) are
representative of at least three independent
experiments.
(E) Supernatants of unsorted Prdm1+/gfp and
Prdm1gfp/gfp B cells cultured in LPS were im-
munoprecipitated and subjected to immuno-
blotting with an anti-IgM. A representative of
two independent experiments is shown.be ASC regardless of their Synd-1 expression status (Kal-
lies et al., 2004). GFP was also detected in Prdm1gfp/gfp
B cell cultures, but these cells lacked Synd-1 (Figure 2A).
ELISpot analysis confirmed the presence of large num-
bers of ASC in the Prdm1+/gfp B cell cultures, but ELISpots
were also produced from cultures of Prdm1gfp/gfp B cells
(Figure 2B). Whereas Prdm1+/gfp or wild-type cultures
yielded mainly large and prominent ELISpots, those gen-
erated by Prdm1gfp/gfp B cell cultures were smaller and
less pronounced (Figure 2C). The presence of low-titer
Ig in the supernatants of Prdm1gfp/gfp cultures was con-
firmed by ELISA (Figure 2D). Interestingly, B cells cultured
in anti-CD40+IL4+IL5 were less affected by the loss of
Blimp-1 function than those cultured in the presence of
LPS. To exclude nonspecific mechanisms of Ig release,
such as shedding ofmembrane-bound IgM into the super-
natant, we immunoprecipitated IgM from LPS-stimulated
B cell cultures. Immunoblotting showed no difference in
the molecular weight of the IgM derived from either cul-
ture, indicating that Blimp-1 mutant cells produce low
amounts of the secreted form of IgM (Figure 2E).
The expression of GFP in stimulated mutant B cells
suggested that they had initiated ASC differentiation and
that these cells were the source of the Ig observed in
Prdm1gfp/gfp cultures. To confirm this assumption, we di-
rectly compared populations sorted on the basis of GFP
and Synd-1 expression from anti-CD40+IL4+IL5-stimu-
lated cultures. Interestingly, a similar degree of B220
downregulation was observed in GFP+Synd-1 cells from
each genotype, suggesting that these cells had indeed ini-
tiated ASCdifferentiation (Figure 3A). Sorting of GFP+ cells
from Prdm1+/gfp and Prdm1gfp/gfp cultures confirmed that558 Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc.GFP expression correlated with Ig secretion (Figures 3B
and 3D). Importantly, GFP+Synd-1 cells from either cul-
ture yielded similar numbers of ELISpots (Figures 3B and
3C) and secreted similar amounts of total Ig on a per cell
basis (Figure 3D). In line with earlier observations that B
cells stimulated by LPS can differentiate into GFP+Synd-1+
via a GFP+Synd-1 stage (Kallies et al., 2004), sort and
reculture experiments showed that GFP+Synd-1
Prdm1+/gfp cells found in anti-CD40+IL4+IL5 cultures
were precursors of fully differentiated GFP+Synd-1+ ASC
(Figure 3E).
Initiation of the Plasma-Cell Gene-Expression
Program in the Absence of Blimp-1
To examinewhether B cells cultured in anti-CD40+IL4+IL5
were able to regulate genes associated with ASC differen-
tiation in the absence of functional Blimp-1, we sorted
GFP+ and GFP cells according to the gates depicted in
Figure 3A and performed semiquantitative RT-PCR analy-
sis. Surprisingly,we found thatGFP+Prdm1gfp/gfpASChad
downregulatedPax5 transcription and initiated expression
of Igj and Xbp1, suggesting that early steps of ASC dif-
ferentiation had occurred independently of Blimp-1
(Figure 3F). Similarly, the splicing of IgHmRNA into the se-
creted and membrane forms was regulated appropriately
in both Blimp-1-sufficient and mutant GFP+Synd-1
ASC. Prdm1gfp/gfp B cells, however, failed to upregulate
Irf4 (Figure 3F).
The downregulation of Pax5was quantified by real-time
RT-PCR, which showed a substantial decrease in Pax5 in
Prdm1gfp/gfp GFP+Synd-1 ASC, albeit to a lesser degree
than in the equivalent population of Prdm1+/gfp ASC (RNA
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in the Absence of Blimp-1 Function
Prdm1+/gfp and Prdm1gfp/gfp B cells were cul-
tured in the presence of a combination anti-
CD40+IL4+IL5 for 4 days and examined for
GFP and Synd-1. Data in this figure are repre-
sentative of 2–3 independent experiments.
(A) B220 expression was determined on cells
gated as indicated.
(B–F) Cells of the indicated genotypes were
sorted according to the gates depicted in (A).
(B and C) Sorted populations were subjected
to ELISpot assays with (B) showing the fre-
quency of Igk ELISpots (data represent the
mean of triplicatewells ± SEM) and (C) showing
representative ELISpot wells.
(D) Igk secretion by equivalent numbers of the
indicated populations as measured by ELISA.
Data are the means ± SEM of triplicate mea-
surements.
(E) R2 (GFP+Synd-1) and R3 (GFP+Synd-1+)
cells from Prdm1+/gfp B cells cultured in anti-
CD40+IL4+IL5 for 3 days were sorted and
reanalyzed (left) or recultured for an additional
22 hr (right).
(F) Sorted populations were subjected to semi-
quantitative RT-PCR analysis for the indicated
genes. Prdm1 primers span exons 7–8 (not
expressed from the truncated allele).expression reduced by 62.5% versus 84.1%, respec-
tively, Figure 4A). In agreement with this, real-time RT-
PCR confirmed the upregulation of the Pax5-repressed
genes Igj and Xbp1 in the Blimp-1 mutant ASC, although
again this effect was less pronounced than in Prdm1+/gfp
ASC (Figure 4A). Importantly, the spliced form of Xbp1
was also detected, suggesting the expression of func-
tional XBP-1 in Blimp-1 mutant ASC (Figure 4C). Suppres-
sion of Pax5 protein expression was also evident, as was
increased production of IgM and Igk (Figure 4B). Thus,
Blimp-1mutant B cells, while not capable of differentiatingto fully secretory ASC, initiated the differentiation pathway
that resulted in some Ig secretion in vitro.
IRF-4 has been shown to be essential for ASC differen-
tiation, so we speculated that the lack of Irf4 upregulation
in Prdm1gfp/gfp B cells was responsible for their failure to
differentiate into high-titer Ig-secreting cells. However,
retroviral overexpression of IRF-4 in Prdm1gfp/gfp B cells
was not sufficient to substantially increase Ig secretion,
whereas, as expected, enforced expression of Blimp-1
resulted in markedly elevated Ig production (Figure 4D).
Ectopic expression of IRF-4 also failed to induce Igj,Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 559
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Program in the Absence of Blimp-1
(A) Real-time PCR of populations sorted ac-
cording to the gates depicted in Figure 3A.
Data are presented as relative to Hprt mRNA.
The mean ± SEM of three biological replicates,
each assayed in triplicate, is shown. Relative
expression of Pax5 mRNA in R2 compared to
R1 are indicated (left). p values for statistical
significance were derived by the paired Stu-
dent’s t test.
(B) Immunoblot analysis of populations as in
(A). Protein extracts equivalent to 23 105 cells
were loaded per lane. A nonspecific protein
was used as a loading control. A representative
of three experiments is shown.
(C) Cells of the indicated genotype were sorted
according to GFP expression and subjected to
RT-PCR. Primers detect the full-length un-
spliced (u) and spliced (s) forms of Xbp1.
Data are representative of three independent
biological replicates.
(D) Enforced expression of IRF-4 is not suffi-
cient to rescue high Ig secretion in the absence
of Blimp-1. Purified splenic B cells of the indi-
cated genotypes were cultured in the presence
of anti-CD40+IL4+IL5 and transduced with
retrovirus encoding either Irf4, Prdm1, or the
empty MCSV virus as control. After puromycin
selection, live cells were cultured overnight and
supernatants analyzed for total Ig by ELISA.
Data are themean ± SEMof triplicatemeasure-
ments and are representative of three indepen-
dent experiments.
(E) Cells of the indicated genotypes either unin-
fected or transduced with Prdm1- or Irf4-ex-
pressing retroviruses were subjected to semi-
quantitative RT-PCR analysis for the indicated
genes. Irf4 primers detect both endogenous
and retrovirally derived transcripts whereas
the Irf4 (UTR) primers detect only the endoge-
nousmRNA. A representative of three indepen-
dent experiments is shown.Xbp1, or endogenous Irf4 in the absence of Blimp-1,
whereas forced expression of Blimp-1 in Prdm1gfp/gfp B
cells resulted in increased amounts of Igj and Xbp1 but
was, surprisingly, not sufficient to induce Irf4 (Figure 4E).
These data suggest that Blimp-1 regulates factors other
than Irf4 to promote ASC differentiation.
Suppression of Pax5 Activity in B Cells Precedes
Blimp-1 Expression
The observation that ASC differentiation was initiated in
the absence of functional Blimp-1 was surprising and led
us to examine the early events in this process upstream
of Blimp-1. Pax5 is an essential regulator that maintains
B cell identity and suppresses ASC differentiation (Delogu
et al., 2006; Nera et al., 2006), so the downregulation of
Pax5 represented an attractive candidate as the differen-
tiation-initiating event. It has been proposed that Pax5 is
a direct target of Blimp-1-mediated repression (Lin et al.,
2002). The data described above, however, suggested
that the initial downregulation of Pax5 was independent560 Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc.of Blimp-1. To examine Pax5 activity in several different
B cell populations, we made use of the recent finding that
a number of target genes repressed by Pax5, including
thoseencoding the receptor tyrosine kinaseFlt3, theadhe-
sion molecule embigin (Delogu et al., 2006; Holmes et al.,
2006), and the inhibitor receptor PD-1 (Nutt et al., 1998),
are re-expressed upon silencing of Pax5 during B cell dif-
ferentiation. Freshly isolated resting splenic Prdm1+/gfp
B cells expressed very low amounts of Flt3, embigin, and
PD-1 (Figure 5A and data not shown). However, as early
as 24 hr after culture in the presence of LPS or anti-
CD40+IL4+IL5, expression of all three molecules was
readily detected on a subset of stimulated B cells (data
not shown). After 3 days, the majority of LPS-stimulated
GFPB cells expressed Flt3, embigin, and PD-1, whereas
a smaller fraction of anti-CD40+IL4+IL5-stimulated GFP
B cells stained positive for these molecules (Figure 5A
and data not shown). Importantly, the expression of these
genes occurred in GFP cells, suggesting that derepres-
sion of Pax5 target genes preceded Blimp-1 induction.
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in the Expression of Pax5 Target Genes
in Activated B Cells
(A) Resting splenic B cells were isolated from
Prdm1+/gfp mice and cultured in the conditions
indicated. Freshly isolated B cells and cells at
day 3 of culture were analyzed for the expres-
sion of embigin or Flt3.
(B) Resting Prdm1gfp/gfp splenic B cells were
cultured in LPS for 3 days and stained for
embigin and Flt3.
(C) Naive wild-type mice were analyzed for
embigin expression in mature B cell subsets
as indicated (left). Splenic B cells of mice
immunized with NP-KLH were analyzed for
embigin expression after 7 days (right). B cell
subsets were defined as following: follicular
B cells (CD23+CD21loIgMlo), MZ B cells
(CD23CD21hiIgMhi), B1, peritoneal B1 B cells
(B220loCD5+). After immunization, B cells were
defined as non-GC cells (B220+PNAlow), GC
cells (B220+PNAhigh). ASC from Prdm1+/gfp
mice were Synd-1highGFP+.
(D) Expression of CD23 on peritoneal B1 cells
(left, solid line) in comparison to splenic (B220+)
B cells (left, broken line) and on splenic B cells
from Prdm1+/gfp mice cultured in LPS for
3 days (right). Results in this figure are repre-
sentative of 2–4 independent experiments.This interpretation was confirmed by the observation that
activated Prdm1gfp/gfp B cells also expressed these Pax5
target genes (Figure 5B).
To determine whether the release of Pax5-mediated
gene repression occurred in vivo, we examined embigin
expression in various mature B cell subsets in naive and
immunized mice. Embigin staining was found constitu-
tively onmyeloid and splenic T cells whereas only aminor-
ity of splenic B cells was embigin+ (Figure 5C). A more de-
tailed analysis of the splenic B cell compartment revealed
that embigin was restricted to marginal zone (MZ) B cells,
whereas follicular B cells were embigin (Figure 5C). In line
with their predisposition to ASC differentiation (Fairfax
et al., 2007), peritoneal B1 B cells were uniformly embigin+
(Figure 5C). The proportion of the embigin+ B cell popula-
tion in spleen increased slightly after immunization with
NP-KLH (Figure 5C), but the representation of embigin+
cells wasmarkedly increased among the PNAhigh GC cells
and essentially all ASC were embigin+ (Figure 5C). Similar
results were obtained with PD-1 and Flt3, although Flt3
was subsequently silenced in ASC by a distinct mecha-
nism (Figure 5A and data not shown).The re-expression of Pax5-suppressed genes promp-
ted us to examine whether the expression of Pax5-acti-
vated genes, including Cd23 (Visan et al., 2003), Cd19,
Cd79a (Nutt et al., 1998), and Blnk (Schebesta et al., 2002)
were alsomodulated in activatedBcells. Indeed,we found
that CD23 had a complementary expression profile to em-
bigin, with low expression on peritoneal B1 and GC B cells
when compared to splenic B cells, and that CD23 was
markedly decreased when B cells were activated in vitro
(Figure 5D). Molecular analysis further demonstrated that
downregulation of Cd79a and Blnk occurred in Flt3+GFP
B cells as well as peritoneal B1 cells (Figure 6A).
The modulation of Pax5 function in activated B cells
could be induced by transcriptional or posttranslational
regulation of Pax5. To distinguish between these possibil-
ities, we sorted Prdm1+/gfp B cells from LPS cultures
according to GFP and Flt3 expression and subjected nu-
clear protein extracts to immunoblotting (Figure 6B). The
amount of Pax5 was similar in all GFP subsets, irrespec-
tive of Flt3 expression, whereas Pax5 protein was down-
regulated in both GFP+ fractions that, as expected, ex-
pressed Blimp-1, suggesting that the alleviation of theImmunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 561
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translationally.
To examinewhether the altered Pax5 activity seen in the
Flt3+ B cell fraction from Prdm1gfp/gfpmice was due to de-
creased or absent binding of Pax5 to DNA, we performed
electro-mobility shift assays (EMSA) and chromatin immu-
noprecipitation assays (ChIP) on B cells sorted according
Figure 6. Diminished Expression of Pax5-Activated Genes in
B Cell Subsets and Unchanged Pax5 DNA Binding in Cultured
B Cells
(A) Real-time RT-PCR analysis of LPS-cultured splenic B cells sorted
from Prdm1+/gfp mice according to Flt3 and GFP expression (top) or
sorted peritoneal B1 and splenic follicular B cells (Fo) (bottom). Data
are presented as relative to Hprt with one sample arbitrarily set to
one. Expression was analyzed in triplicate and data are the mean ±
SEM of a representative of three biological replicates.
(B) Prdm1+/gfp B cells were cultured in LPS for 4 days, stained for Flt3,
and sorted according to the quadrants depicted in Figure 5A (lower,
left). Nuclear extracts from the equivalent of 1.5–2 3 105 sorted or
freshly isolated resting B cells (rest) were subjected to an immunoblot
with Pax5 and Blimp-1 antibodies.
(C) ChIP assay of Pax5 binding to the Flt3 promoter. LPS-cultured
splenic B cells were sorted as in (B) and the Flt3+ and Flt3 fractions
were subjected to ChIP ± Pax5 antibody. 1:3-fold serial dilutions of
the ChIP product was amplified with primers that span the Pax5-bind-
ing sites in the Flt3 promoter. Pax5/ or wild-type pro-B cells were
used as controls. Data are representative of two experiments.562 Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc.to Flt3 expression. However, neither EMSA (data not
shown) nor ChIP (Figure 6C) demonstrated diminished
binding of Pax5 to the Flt3 promoter, suggesting that de-
creased occupancy of its binding sites is unlikely to ex-
plain the decreased Pax5 activity observed.
DISCUSSION
Loss of Blimp-1 function in mouse B cells has been stud-
ied previously via conditional mutagenesis (Shapiro-She-
lef et al., 2003). In that model,Prdm1was specifically inac-
tivated in B cells by Cre under the control of the Cd19
promoter. Similarly to the data presented here, Prdm1fl/fl
Cd19Cre mice showed strongly reduced, but clearly de-
tectable, amounts of serum Ig and a low Ig secretion
in vitro (Shapiro-Shelef et al., 2003). This and the failure
of these mice to mount an antigen-specific Ig response
led to the conclusion that Blimp-1 is absolutely required
for ASC differentiation (Shapiro-Shelef et al., 2003). How-
ever, the incomplete Cre-mediated deletion of the condi-
tional allele in that study made it difficult to determine
whether Blimp-1-independent differentiation pathways
existed. Themodel for Blimp-1 deficiency presented here,
viaRag1/mice reconstituted with Prdm1gfp/gfp fetal liver
stem cells, has two principle advantages. First, because
Rag1/ mice lack endogenous B cells and serum Ig,
any detectable Ig must derive from the Blimp-1 mutant
B cells. The second advantage of our mouse model is
the ability to track Blimp-1 expression by means of GFP
(Kallies et al., 2004, 2006), which enables us to detect cells
with an active Prdm1 locus on a single-cell basis in the
presence or absence of functional Blimp-1 protein and
to track defects in these B cells to a distinct developmen-
tal state.
By a number of criteria, we have shown here that
Prdm1gfp/gfp mice have low titers of serum Ig. This raised
thequestion ofwhether this Igwasproducedbya rare, fully
functional, ASC population lacking Blimp-1 or was the re-
sult of low secretion by a Blimp-1-independent stage of
ASC differentiation. An earlier study suggested that B1 B
cells are capable of secreting Ig in the absence of Blimp-1
expression (Tumang et al., 2005). However, recent studies
have shown that Ig secretion from B1 cells crucially de-
pends on, and is paralleled by, Blimp-1 expression (Fairfax
et al., 2007; Savitsky andCalame, 2006), indicating that full
ASC differentiation from all B cell subsets depends on
Blimp-1. Our data demonstrate the existence of a Blimp-
1-independent phase of ASC differentiation, and we pro-
pose the term ‘‘preplasmablast’’ to describe this transient
and low Ig-secreting stage of differentiation. We have not
been able to detect any GFP+ B cells in the GCs of
Prdm1gfp/gfp mice, so it appears likely that, at least in the
absence of Blimp-1, preplasmablasts arise either in post-
GC cells or via an extrafollicular pathway. Interestingly,
we observed a larger fraction of GFP+ B cells in Blimp-1-
deficientmice than in controls, suggesting that preplasma-
blast cells accumulate because of their failure to proceed
along the differentiation pathway. Alternatively, the large
number of preplasmablasts in Prdm1gfp/gfp mice could be
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titers of natural antibody as previously proposed (Agenes
and Freitas, 1999).
In addition to Blimp-1, XBP-1 and IRF-4 are two tran-
scription factors known to be essential for ASC generation
(Mittrucker et al., 1997; Reimold et al., 2001). Whereas
Xbp1 is considered to be downstream of Blimp-1 (Shaffer
et al., 2004), we show here that initial induction of Xbp1 is
largely the result of loss of Pax5-mediated suppression,
and we propose that the subsequent high expression of
Xbp1 is a consequence of the UPR rather than being di-
rectly mediated by Blimp-1. In keeping with this, enforced
expression of XBP-1 in Prdm1/ B cell cultures does not
rescue ASC differentiation (Shapiro-Shelef et al., 2003).
The relationship between Blimp-1 and IRF-4 is less clear.
Although a recent study demonstrated that Blimp-1 ex-
pression occurs independently of IRF-4 (Klein et al.,
2006), a subsequent report suggested that IRF-4 directly
regulatesPrdm1 (Sciammas et al., 2006). Our observation,
that high Irf4 transcription did not occur in the absence
of Blimp-1, supports the notion that Irf4 is downstream
of Blimp-1. Ectopically expressed IRF-4 was, however,
not sufficient to complement the Blimp-1 deficiency. Inter-
estingly, the ectopic expression of Blimp-1 in Prdm1gfp/gfp
B cells increased Ig secretion, but did not induce upregu-
lation of Irf4. This finding suggests that Blimp-1 and IRF-4
are regulated independently from each other, a conclusion
supported by the recent observation that cultured B cells
from Vav-deficient mice show impaired Blimp-1 induction,
but IRF-4 expression is unchanged (Stephenson et al.,
2006). In summary, while initiation of ASC differentiation
is Blimp-1 independent, completion of this process de-
pends on the coordinate expression of all three factors,
Blimp-1, IRF-4, and XBP-1.
A key question in the study of the transcriptional events
that control ASC differentiation is how the stable long-
term transcriptional program of B cells is silenced and re-
placed by the fundamentally different program that gov-
erns the plasma-cell fate. The current consensus is that
this process is orchestrated by the direct repression of
the B cell fate by Blimp-1 (Shapiro-Shelef and Calame,
2005). The data presented here, however, challenge this
concept and provide a significant revision to this model
by identifying a central role for the B cell maintenance-
factor Pax5.
Mature B cells express Pax5 and ASC differentiation is
paralleled by its downregulation (Delogu et al., 2006).
Pax5 is known to regulate Ig production by repressing
Igh (Linderson et al., 2004) and Igk (Roque et al., 1996)
transcription as well as expression of Xbp1 (Reimold et al.,
1996) and Igj (Rinkenberger et al., 1996). Loss of Pax5 is
sufficient to induce IgM secretion and Blimp-1 expression
(Delogu et al., 2006; Nera et al., 2006). A limitation of pre-
vious studies examining ASC differentiation was that they
were conducted on Blimp-1-sufficient B cells, thereby
making it impossible to separate the stages in differentia-
tion that were solely dependent on Pax5 repression from
subsequent steps that were dependent on Blimp-1 induc-
tion. Microarray studies performed on wild-type andBlimp-1-deficient B cells stimulated under conditions that
support ASC differentiation (Shaffer et al., 2004) are again
of limited utility in addressing this question, because the
majority of cells in the cultures remain undifferentiated B
cells and thus are not likely to identify Blimp-1-indepen-
dent gene-regulatory processes occurring in a subset of
cells.
By using the Blimp-1 GFP reporter, we show here that
Pax5 is rapidly extinguished in Blimp-1+ cells, a finding
compatible with Pax5 being a direct target of Blimp-1 re-
pression (Lin et al., 2002). However, we further de-
monstrate that the early phase of Pax5 downregulation
occurs independently of Blimp-1, because both GFP+
Prdm1gfp/gfp and Prdm1+/gfp preplasmablasts showed
similar Pax5 downregulation and induction of Pax5-re-
pressed genes, suggesting that other factors are involved
in this process. In support of this conclusion, ectopic ex-
pression of Blimp-1 in some models did not silence
Pax5, suggesting that repression of the Pax5 locus de-
pends on factors other than Blimp-1 (Sciammas and
Davis, 2004).
To further examine the role of Pax5 in initiating the tran-
scriptional cascade leading to ASC, we took advantage
of the recent comprehensive reports of Pax5-repressed
genes (Delogu et al., 2006; Nera et al., 2006). Three mole-
cules, Flt3, embigin, and PD-1, were particularly advanta-
geous because they are cell-surface molecules whose
expression is repressed by Pax5 upon B cell commitment,
but reactivated during ASC differentiation. Examination of
the expression kinetics of these proteins demonstrated
that they were induced before, and thus in the absence
of, Blimp-1. The simultaneous derepression of three inde-
pendent Pax5 target genes provides compelling evidence
that Pax5 activity is modulated prior to Blimp-1 induction
in ASC differentiation. Importantly, we also found evi-
dence for the Blimp-1-independent regulation of Pax5 ac-
tivity by examining the expression of the Pax5-activated
target genes Cd23, Cd79a, and Blnk (Nutt et al., 1998;
Schebesta et al., 2002; Visan et al., 2003). All three genes
were distinctly downregulated in the Flt3+ fraction before
the onset of Blimp-1 expression. These changes were,
however, specific for individual genes: the expression of
another Pax5-activated gene Cd19 was found to be un-
changed in Flt3+ B cells. Interestingly, we found that
some in vivo B cell populations, including a large fraction
of MZ and GC B cells, as well as B1 cells, resembled
Flt3+ B cells in vitro in that they showed altered expres-
sion of Pax5 target genes. This poised gene-expression
profile may explain the rapid kinetics by which both B1
and MZ B cells differentiate into ASC in vitro (Fairfax
et al., 2007).
The suppression of Pax5 activity was independent of
changes in its protein expression or in vivo DNA binding,
raising the possibility that changes in the expression or ac-
tivity of other transcription factors during B cell activation
alter Pax5 activity. Indeed, it has been shown that Pax5
function is modulated by the relative abundance of Id2
(Gonda et al., 2003) and PU.1 (Linderson et al., 2004).
We propose that a similar mechanism regulates theImmunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 563
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The stages of cellular differentiation froma rest-
ingBcell to anASCand theassociatedmarkers
are indicated. The relative Pax5 and Blimp-1
expression and function is indicated. [ indi-
cates positive influence on gene expression or
function;t indicates repressive activity.initiation of ASC differentiation, although the identity of the
inhibitory factor operating on Pax5 is currently unknown.
Over the past few years a model of the transcriptional
regulation of the terminal differentiation of B cells to the
ASC fate has been proposed. The central point of this
model is the mutually antagonistic interactions between
a number of transcriptional repressors, including Pax5,
BCL6, and Blimp-1 (Shapiro-Shelef and Calame, 2005).
Although this model describes the delineation and tran-
scriptional stability of the B cell and ASC states, it does
not adequately explain how the mutual transcriptional re-
pression is lifted to allow differentiation. The data pre-
sented here provide a number of insights into the earliest
events in this process and allow us to extend the current
model (Figure 7). We propose that in the resting state, B
cells stably express Pax5, which represses the ASC pro-
gram. Upon cell activation, Pax5 function is modified,
through an unknown mechanism, altering the expression
of a number of Pax5 target genes important for the ASC
fate. We propose that this event initiates the ASC program
and generates the preplasmablast stage, which is charac-
terized by downregulation of Pax5, low Ig secretion, and
Blimp-1 induction. Blimp-1 then silences Pax5 transcrip-
tion, and thus the B cell program, by a classical feedback
inhibition mechanism. Although the available evidence
suggests that the preplasmablast is a transient step in nor-
mal differentiation, cells accumulate at this point in the
absence of Blimp-1. This model provides a framework to
investigate the interaction of Pax5 and Blimp-1 in control-
ling the B cell and ASC fates, respectively, as well as to in-
vestigate the roles played by other molecules, in particular
OBF-1, Bach2, BCL6, and IRF-4, in the process.
EXPERIMENTAL PROCEDURES
Transplantation of Fetal Liver Cells
E14 embryos from intercrossed Prdm1+/gfp (C57BL/6 Ly5.2) mice were
genotyped and fetal liver chimeras generated in Rag1/ (C57BL/6
Ly5.1) recipients and analyzed after 8 weeks as described (Kallies
et al., 2004). All animal experiments were conducted according to564 Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc.the protocols approved by the Melbourne Health animal ethics com-
mittee.
Flow Cytometry
mAb against CD19 (1D3), B220 (RA3-6B2), Ly5.2 (ALI-4A2), Flt3
(A2F10.1), IgM (331.12), CD5 (Ly-1), and CD21 (7G6) were purified
from hybridoma supernatant and conjugated in the author’s labora-
tory. Anti-Synd-1 (281-2), PD-1 (J43), and CD23 (B3B4) were obtained
from BD Biosciences, and peanut agglutinin (PNA) was from Vector
Laboratories. The rat embigin mAb will be described elsewhere
(S.L.N., unpublished). Cells were analyzed on an LSR and cell sorting
was carried out on a DiVa flow cytometer (BD Biosciences).
ELISA and ELISpot Assay
Serum and supernatant Ig amounts were measured by ELISA as de-
scribed previously (Hasbold et al., 2004). Mucosal IgA was isolated
from fecal samples by the following procedure. 1 ml of 0.1 mg/ml soy-
bean trypsin inhibitor (Sigma-Aldrich) in PBS was added per 0.1 g of
feces, then vortexed in a mini-bead beater for 10 s at 2500 rpm. Debris
was removed by centrifugation and supernatants were assayed for IgA
by ELISA. ELISpot assays were performed on MultiScreen-HA filter
plates (Millipore). Cells were incubated for 4 hr at 37C on precoated
96-well filter plates and developed with the appropriate enzyme-
conjugated secondary antibodies and substrates.
Immunohistochemistry
Small intestines were harvested into OCT (Sakura Finetek) and frozen
on dry ice. 5 mm sections were cut onto polylysine-coated slides, fixed
in acetone, rehydrated in PBS, and blocked with PBS/10% FCS before
staining with anti-mouse IgA-HRP. Staining was visualized with diami-
nodenzidine (Sigma-Aldrich) and counterstained with haematoxylin.
In Vivo Induction of ASC
Mice were injected intravenously with 3 mg E. coli LPS (O111:B4,
Sigma-Aldrich) and analyzed at days 3 and 7. Immunization was with
a single intraperitoneal injection of 100 mg 4(hydroxy-3)-nitrophenyl
(NP) coupled to keyhole limpet hemocyanin (KLH) in the ratio of 13:1,
and IgG1 ASC activity in 500 sorted GFP+ populations was determined
with NP-specific ELISpot as described (Smith et al., 1997).
In Vitro Cell Culture
Naive splenic B cells were purified by Percoll gradient centrifugation
and B220 magnetic bead purification (Miltenyi Biotec) as described
(Hasbold et al., 2004). Purified cells were cultured at 1 3 105/ml with
optimal concentrations of CD40 antibody (1C10, 10 mg/ml), IL4
Immunity 26, 555–566, May 2007 ª2007 Elsevier Inc. 565
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Antibody Secretion in the Absence of Blimp-1(500 U/ml, R&D Systems), and IL5 (2 ng/ml, R&D Systems). 4 3 105
cells/ml were used for LPS (20 mg/ml) stimulation.
Western Blotting and Immunoprecipitation
The Pax5 mAb was generated in rats by immunization with a purified
GST-Pax5 fusion protein consisting of amino acids 154–284 of mouse
Pax5. mAbs were screened by immunoblotting via Pax5/ and wild-
type pro-B cell lines (Nutt et al., 1998). Reactivity with an endogenous
protein of the appropriate size for Pax5 (50 kDa) protein was specif-
ically detected for clone 1H9. The Blimp-1 mAb and immunoblotting
was as previously described (Kallies et al., 2004). Igk-HRP and IgM-
HRPwere fromSouthern Biotechnology Associates. Serum IgG immu-
noprecipitation was carried out with protein G-sepharose. Protein
extracts corresponding to equal cell numbers were loaded onto the
gel, with equal protein loading confirmed with Ponceau Red stains of
the membrane after protein transfer.
ChIP
For ChIP analysis, splenic B cells ofPrdm1+/gfpmicewere culturedwith
20mg/ml LPS.After 3days,GFPFlt3+ andGFPFlt3cellswere sorted
and fixed with 0.5% formaldehyde. 2.53 106 cells were used for each
ChIP experiment as described (Holmes et al., 2006). 53 106 wild-type
and Pax5/ pro-B cells (Nutt et al., 1998) were used as controls.
RT-PCR Analysis
In vitro cultured B cells were sorted and subjected to RT-PCR accord-
ing to standard procedures. Primer sequences are as reported (Cor-
coran et al., 2005), except for the following: Prdm1 50-AACACGTGGTA
CAACCCAAAG, 50-AGGCTGCAGAGATGGATGTAG; Blnk 50-CCCAC
CCAGAAACCTGTC, 50-TTCAGCCTCCTGGTCTGC; Cd79a 50-TCT
TCTTGTCATACGCCTGTTTG, 50-GATGTTAGACTGAAGGCTGAACC;
Irf4 50-GGACTACAATCGTGAGGAGGAC, 50-ACGTCACAGGACATTG
ATATGG. Detection of the spliced form of Xbp1 was as described
(Iwakoshi et al., 2003). Real-time PCR was carried out as described
(Holmes et al., 2006) with the products being quantified in relation to
Hprt amounts.
Retroviral Infection
The MSCV-IRF4-Puro and MSCV-Puro retroviral vectors were as re-
ported (Tamura et al., 2005). Transfection of Phoenix cells and subse-
quent spin infection was performed as described (Corcoran et al.,
2005). Purified splenic B cells were activated with anti-CD40+IL4+IL5
for 40 hr (as described above) and used for spin infections before being
placed in the samemedium. After overnight culture, transduced B cells
were selected by puromycin (4 mg/ml) for 48 hr. Surviving cells were
then counted and analyzed by flow cytometry or recultured in media
at 13 105 cells/ml overnight, and the supernatant was assayed for Ig.
Supplemental Data
One figure is available at http://www.immunity.com/cgi/content/full/
26/5/555/DC1/.
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